Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD33B pseudogene 9 (ANKRD33BP9) is a human pseudogene located in the genome and denoted by the approved symbol ANKRD33BP9 (HGNC:56301). Pseudogenes are DNA sequences that resemble known genes but are nonfunctional due to mutations or disruptions that prevent the production of a functional protein product. They are often derived from protein-coding genes but lack the ability to encode proteins and usually do not have direct biological roles, though some may be transcribed into RNA with potential regulatory effects. ANKRD33BP9 is classified as a pseudogene of the ankyrin repeat domain 33B family, without evidence for protein product or direct involvement in human disease, molecular signaling, or pharmacological targeting. No evidence suggests that ANKRD33BP9 has a role as a therapeutic or diagnostic target, nor are there known drugs, biomarkers, or notable safety concerns related to this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ANKRD33B pseudogene 9 (ANKRD33BP9).